Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2–neurturin) to patients with idiopathic Parkinson's disease: an open-label, phase I trial

著者: William J. Marks, Jill L. Ostrem, L. Verhagen, Philip A. Starr, Paul Larson, Roy A.E. Bakay, Robin Taylor, Deborah A. Cahn‐Weiner, A. Jon Stoessl, C. Warren Olanow, Raymond T. Bartus - The Lancet 2008 被引用: 587